Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) just unveiled an update.
FIL Limited has increased its stake in Recce Pharmaceuticals Ltd., now holding 16,755,072 shares, which represents a 6.40% voting power in the company. This change in substantial holding reflects FIL Limited’s continued investment in Recce Pharmaceuticals, potentially signaling confidence in the company’s strategic direction and its innovative approach to tackling antibiotic resistance, which could have significant implications for stakeholders and the broader pharmaceutical industry.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development of new classes of synthetic anti-infectives designed to address the urgent global health threat posed by antibiotic-resistant superbugs and emerging viral pathogens.
Average Trading Volume: 215,192
Technical Sentiment Signal: Sell
Current Market Cap: A$78.45M
Find detailed analytics on RCE stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue